Novo Nordisk comments on role of off-label use in Ozempic shortfall

Novo Nordisk comments on role of off-label use in Ozempic shortfall

Source: 
Medical Marketing and Media
snippet: 


Novo Nordisk recently disclosed a shortfall of Ozempic and said that the use of the diabetes injection for weight loss has exacerbated the existing supply crunch.